Education
About Us
Working with TipRanks
Follow Us
Qiagen NV (QGEN)
NYSE:QGEN
QGEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$37.63 - $51.88
Previous CloseN/A
Volume260.87K
Average Volume (3M)1.39M
Market Cap
$11.04B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)122.1
Beta0.73
Next Earnings
Aug 05, 2025EPS Estimate
0.6Last Dividend Ex-Date
Jan 29, 2025Dividend Yield2.46%
Share Statistics
EPS (TTM)0.55
Shares Outstanding216,556,000
10 Day Avg. Volume1,651,168
30 Day Avg. Volume1,390,226
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$52.33Price Target Upside2.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
Capital AllocationQiagen's announcement of its first-ever dividend and a $500 million share buyback demonstrates a strong capital allocation strategy.
Management And StrategyManagement is executing well on margin expansion and is confident in exceeding its 2028 operating margin target ahead of schedule.
Research And DevelopmentThe European Commission's Horizon Europe framework is expected to boost Qiagen's growth potential through increased R&D investment and participation in Horizon-funded projects.
Bears Say
Growth ChallengesThere is uncertainty about the durability of Qiagen's top-line growth, impacting the immediate upgrade of stock ratings.
Product Launch And PerformanceSample technologies experienced a decline in core growth due to ongoing instrument softness ahead of new product launches.
Segment PerformanceCore growth in Qiagen's genomics and NGS segment declined and fell below expectations, indicating challenges in certain areas.
Qiagen News
QGEN FAQ
What was Qiagen NV’s price range in the past 12 months?
Qiagen NV lowest stock price was $37.63 and its highest was $51.88 in the past 12 months.
What is Qiagen NV’s market cap?
Qiagen NV’s market cap is $11.04B.
When is Qiagen NV’s upcoming earnings report date?
Qiagen NV’s upcoming earnings report date is Aug 05, 2025 which is in 5 days.
How were Qiagen NV’s earnings last quarter?
Qiagen NV released its earnings results on May 07, 2025. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.503 by $0.047.
Is Qiagen NV overvalued?
According to Wall Street analysts Qiagen NV’s price is currently Undervalued.
Does Qiagen NV pay dividends?
Qiagen NV pays a Annually dividend of $1.26 which represents an annual dividend yield of 2.46%. See more information on Qiagen NV dividends here
What is Qiagen NV’s EPS estimate?
Qiagen NV’s EPS estimate is 0.6.
How many shares outstanding does Qiagen NV have?
Qiagen NV has 216,556,000 shares outstanding.
What happened to Qiagen NV’s price movement after its last earnings report?
Qiagen NV reported an EPS of $0.55 in its last earnings report, beating expectations of $0.503. Following the earnings report the stock price went down -1.108%.
Which hedge fund is a major shareholder of Qiagen NV?
Currently, no hedge funds are holding shares in QGEN
Qiagen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$52.33 (2.47% Upside)
$52.33 (2.47% Upside)
Blogger Sentiment
Neutral
QGEN Sentiment 50%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 90.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.7%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.64%
12-Months-Change
Fundamentals
Return on Equity
2.67%
Trailing 12-Months
Asset Growth
-4.49%
Trailing 12-Months
Company Description
Qiagen NV
Qiagen N.V. is a Netherlands-based holding company and a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights. The company operates in the life sciences and molecular diagnostics sectors, offering an extensive range of products including instruments, consumables, and bioinformatics solutions for laboratories in the healthcare, academia, and industrial sectors. Qiagen's core services assist in the extraction, purification, and analysis of DNA, RNA, and proteins, catering to areas such as infectious diseases, oncology, and genomics research.
QGEN Company Deck
QGEN Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Qiagen delivered a strong start to 2025, exceeding expectations for net sales and earnings. Key product lines showed robust growth, and profitability improved significantly. While challenges remain in the China market and cautious customer spending, the company reaffirmed its full-year outlook and expanded shareholder return options, indicating confidence in its strategy and execution.Read More>QGEN Stock 12 Month Forecast
Average Price Target
$52.33
▲(2.47%Upside)
Technical Analysis
Ownership Overview
0.55% Insiders
19.94% Mutual Funds
0.45% Other Institutional Investors
61.97% Public Companies and
Individual Investors